Adverse Drug Event, Arthritis, Autoimmunity, Oncology
Conditions
Brief summary
In this study, every patient with cancer who is going to be treated by immunotherapy will fill in a form. In this form, we try to determine if he presents rheumatologic complications of his immunotherapy. If the patient answers yes to one question on the form, the patient will be see in rheumatologic consultation to explore his clinical signs. The number of patients referred in consultation thanks to this questionnaire will be compared to the number of patients who would have been spontaneously referred by the oncologist. The aim of this questionnaire is to optimise the management of rheumatological effects secondary to immunotherapy.
Interventions
OTHERFill in a form
Patient will have to fill in a form at each perfusion of immunotherapy to tell if they presents rheumatologic clinical signs
Sponsors
Poitiers University Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient with cancer needed to be treated by immunotherapy
Exclusion criteria
* Patient already treated by immunotherapy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| to determine whether a self-questionnaire completed by a patient treated with immunotherapy can identify more patients with rheumatological side effects related to this treatment, compared to the complaint reported by the patient to the oncologist | ONE YEAR | number of patients referred to a rheumatology consultation thanks to the answers to the questionnaire compared to the number of patients referred to a consultation (from questionnaire and oncologist) |
Countries
France
Contacts
Primary ContactFrancoise Debiais, MD PHD
Backup ContactAlice Bel
Outcome results
None listed